Annual report [Section 13 and 15(d), not S-K Item 405]

STOCKHOLDERS’ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Jun. 30, 2026

SCHEDULE OF KEY INPUTS WARRANT LIABILITY

The key inputs for the warrant liability were as follows as of initial valuation on November 4, 2025:

Key Valuation Inputs
Expected term (years)		2.00
Annualized volatility		92.27	%
Risk-free interest rate		3.58	%
Series C Convertible Preferred Stock per Share Value	$	1,177.54
Dividend yield		0.00	%
Exercise price	$	10,000.00

The key inputs for the warrant liability were as follows as of May 5, 2026 (date of reclassification of warrant liability into equity):

Key Valuation Inputs
Expected term (years)		1.50
Annualized volatility		115.07	%
Risk-free interest rate		3.85	%
Series C Convertible Preferred Stock per Share Value	$	1,073.46
Dividend yield		0.00	%
Exercise price	$	10,000.00

SUMMARY OF WARRANT ACTIVITY

The following table summarizes common stock warrant activity for the years ended June 30, 2026 and 2025:

				Weighted
	Number of			Average
	Warrants			Price Per Share
Outstanding at June 30, 2024		10		$	31.00
Granted		-			-
Exercised		-			-
Cancelled*		-			-
Expired		-			-
Outstanding at June 30, 2025		10		$	31.00
Granted – Common stock warrants		1,200			100.00
Granted – Series C preferred stock warrants		9,900			10,000.00
Exercised – Series C preferred stock warrants		(300	)		10,000.00
Cancelled		-			-
Expired		-			-
Outstanding at June 30, 2026		10,810		$	8,905.64

Exercisable at June 30, 2026		10,810		$	8,905.64
Outstanding and Exercisable:

Weighted average remaining contractual term		1.66
Aggregate intrinsic value	$	-

On March 3, 2025, the Company cancelled all the existing warrants (de minimis number of shares of Series A warrants, Series B warrants, and Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above).